Defensive Sectors Provide Stability
Some sectors tend to perform better when the overall market is under stress. These sectors, known as defensive sectors, provide stability during uncertain times. FMCG is usually the first name that comes to mind in this category, as it caters to essential consumer needs. However, the pharma sector is another strong defensive play that many investors overlook due to a lack of understanding. Historically, pharma stocks have done exceptionally well whenever broader markets have struggled.

Pharma’s Strong Performance After Market Crashes
Looking at past data, the pharma sector has shown its strength after major market downturns. After the 2008 financial crisis, while the Nifty 500 took years to recover, the pharma sector surged ahead, delivering strong returns for investors. The chart of the CNX Pharma Index divided by the CNX 500 over the last 25 years clearly shows how this cycle plays out. Between 2003 and 2008, the overall market was performing well, causing the ratio to decline as pharma stocks underperformed. However, from 2008 to 2015, the broader market struggled while pharma stocks surged, pushing the ratio higher.

A Long Downtrend Followed by a Possible Reversal
From 2015 onwards, pharma stocks saw a prolonged eight-year downtrend, with a temporary rise during the Covid crash when markets fell sharply. While pharma stocks also fell, they did not decline as much as other sectors, causing a small spike in the ratio. The downward trend continued until 2023, but now there are signs that a new cycle is beginning.

The Next Few Years Could Belong to Pharma
If past patterns hold, pharma stocks could be entering a phase where they outperform the general index for the next three to four years. This does not necessarily mean that the broader market will not rise, but rather that pharma stocks may deliver stronger returns relative to the Nifty 500. Investors looking for tactical opportunities should pay close attention to this sector, as it could be at the start of a new uptrend.

Sector Cycles Keep Rotating
Market leadership keeps changing over time. The sectors that have performed well in recent years may slow down, while sectors like pharma, which have been underperforming, may take the lead. This cycle of sector rotation is a normal part of market behavior. For those looking to invest with a strategic approach, it is important to recognize these trends early and position portfolios accordingly.

WeekendInvesting launches – PortfolioMomentum Report

Momentum Score: See what percentage of your portfolio is in high vs. low momentum stocks, giving you a snapshot of its performance and health.

Weightage Skew: Discover if certain stocks are dominating your portfolio, affecting its performance and risk balance.

Why it matters
Weak momentum stocks can limit your gains, while high momentum stocks improve capital allocation, enhancing your chances of superior performance.

Disclaimers and disclosures : https://tinyurl.com/2763eyaz